Otherwise, Tasuku Honjo demonstrated that TCR engagement at the tumor site causes the expression of the PD-1 receptor that binds the PD-1 ligand (PD-L1) on cancer cells, causing the exhaustion of T cells and hampering the antitumor cytotoxic T cell responses (Okazaki et al., 2013). The gene discussed is CD274; the disease is neoplasm.